TACROLIMUS - ANVISA Registration 10345162343

Access comprehensive regulatory information for TACROLIMUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10345162343 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until Dec 02, 2029.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10345162343
2 Related Devices
Registration Details
ANVISA Registration Number: 10345162343
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Atellica CH Tacrolimus (TACR)
Risk Class III

Registration Details

10345162343

25351667726201996

01449930000190

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Dec 02, 2019

02/12/2029

09/18/2025 19:00:01

Atellica CH Tacrolimus (TACR)
Risk Class III

Registration Details

10345162343

25351667726201996

01449930000190

Company Information

Dates and Status

Dec 02, 2019

02/12/2029

09/18/2025 19:00:01